Physician profile
David Ng
NPI 1942704135
$1,948.82
in general payments reported to CMS, 2019-2025
14 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $266 · 2024: $680 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,720 · Travel and Lodging: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,719.99 |
| Travel and Lodging | $228.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $917.22 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $273.36 | 2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Curonix LLC | $150.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $136.99 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $128.45 | 2025 | |
| Collegium Pharmaceutical, INC. | $96.69 | 2023-2025 | Xtampza, Belbuca |
| Abbvie INC. | $55.99 | 2025 | |
| Spr Therapeutics, INC | $52.06 | 2025 | Sprint Pns System |
| Fidia Pharma USA INC. | $32.26 | 2024 | Hyalgan, Triluron, Hymovis |
| Avanos Medical | $31.74 | 2025 | Trays- All |
| Vertos Medical, INC. | $22.09 | 2024 | Mild Device Kit |
| Tonix Medicines, INC. | $19.26 | 2025 | Tonmya |
| Valinor Pharma, LLC | $17.41 | 2025 | Movantik |
| Pfizer INC. | $15.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.